Literature DB >> 6531961

Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions.

C R Crawford, F A Mukhlis, R Jennings, J S Oxford, D J Hockley, C W Potter.   

Abstract

The zwitterionic, Empigen BB an alkylbetaine based on a C12-C14 alcohol was shown to disrupt influenza A and B viruses in such a way as to retain the biological activity of the surface haemagglutinin (HA) and neuraminidase (NA) antigens. The optimal conditions required to obtain the maximum recovery of HA and NA activity from purified influenza X47 (H3N2) virus concentrate after treatment with Empigen, and the nature and the morphological appearance of the Empigen-treated preparations both before and following a sucrose density gradient purification step, are described. Matrix (M) protein was readily removed during purification, but nucleoprotein (NP) could not be separated from the surface protein activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6531961     DOI: 10.1016/0264-410x(84)90084-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.

Authors:  E T Ben Ahmeida; R Jennings; M Erturk; C W Potter
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Specificity and in vitro transfer of the immunosuppressive effect of detergent-disrupted influenza virus vaccine.

Authors:  T L Smith; R Jennings
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

3.  Zwitterionic detergent solubilisation of HSV-1 surface antigens.

Authors:  R Jennings; T Quasim; R M Sharrard; D Hockley; C W Potter
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 4.  Sanitizing agents for virus inactivation and disinfection.

Authors:  Qianyu Lin; Jason Y C Lim; Kun Xue; Pek Yin Michelle Yew; Cally Owh; Pei Lin Chee; Xian Jun Loh
Journal:  View (Beijing)       Date:  2020-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.